Axon growth inhibition by RhoA/ROCK in the central nervous system
Open Access
- 22 October 2014
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 8, 338
- https://doi.org/10.3389/fnins.2014.00338
Abstract
Rho kinase (ROCK) is a serine/threonine kinase and a downstream target of the small GTPase Rho. The RhoA/ROCK pathway is associated with various neuronal functions such as migration, dendrite development, and axonal extension. Evidence from animal studies reveals that RhoA/ROCK signaling is involved in various central nervous system (CNS) diseases, including optic nerve and spinal cord injuries, stroke, and neurodegenerative diseases. Given that RhoA/ROCK plays a critical role in the pathophysiology of CNS diseases, the development of therapeutic agents targeting this pathway is expected to contribute to the treatment of CNS diseases. The RhoA/ROCK pathway mediates the effects of myelin-associated axon growth inhibitors—Nogo, myelin-associated glycoprotein (MAG), oligodendrocyte-myelin glycoprotein (OMgp), and repulsive guidance molecule (RGM). Blocking RhoA/ROCK signaling can reverse the inhibitory effects of these molecules on axon outgrowth, and promotes axonal sprouting and functional recovery in animal models of CNS injury. To date, several RhoA/ROCK inhibitors have been under development or in clinical trials as therapeutic agents for neurological disorders. In this review, we focus on the RhoA/ROCK signaling pathway in neurological disorders. We also discuss the potential therapeutic approaches of RhoA/ROCK inhibitors for various neurological disorders.Keywords
This publication has 180 references indexed in Scilit:
- NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycansNature Neuroscience, 2012
- Neuroprotection from Stroke in the Absence of MHCI or PirBNeuron, 2012
- The Nogo Receptor Family Restricts Synapse Number in the Developing HippocampusNeuron, 2012
- Myelin suppresses axon regeneration by PIR-B/SHP-mediated inhibition of Trk activityThe EMBO Journal, 2011
- The role of antigen presenting cells in multiple sclerosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Paired Immunoglobulin-like Receptor B Knockout Does Not Enhance Axonal Regeneration or Locomotor Recovery after Spinal Cord InjuryPublished by Elsevier BV ,2011
- Assessing Spinal Axon Regeneration and Sprouting in Nogo-, MAG-, and OMgp-Deficient MiceNeuron, 2010
- Assessment of functional recovery and axonal sprouting in oligodendrocyte-myelin glycoprotein (OMgp) null mice after spinal cord injuryMolecular and Cellular Neuroscience, 2008
- Glial inhibition of CNS axon regenerationNature Reviews Neuroscience, 2006
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000